Pfizer divests $3.05 billion of Haleon shares, cutting its stake to 7.3% in a strategic shift to refocus on core ...

Brookstone Capital Management trimmed its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 11.9% in the fourth ...

Pfizer (NYSE:PFE – Get Free Report) had its price objective lowered by analysts at UBS Group from $31.00 to $29.00 in a ...

Weybridge-based Haleon is a consumer healthcare products manufacturer which owns brands such as Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. According to JPMorgan, Pfizer ...

The trial showed a 'clinically meaningful' and 'statistically significant' improvement when treated with therapy plus BCG, ...

The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction ...

The latest disposal reduced Pfizer's interest in Haleon to 7.3% from 15%. JPMorgan and Morgan Stanley acted as joint global coordinators and joint bookrunners for the sale. GSK sold its remaining 4.2% ...

Purchase of Intra-Cellular will give J&J control of mental health drug Caplyta, which CEO predicts will become a $5 billion ...

Fifteen drugs, including Novo Nordisk's Ozempic and Wegovy, are slated for Medicare price negotiations under the Inflation ...

Many dog owners have already heard about the FDA warning and seen the articles on the terrible side effects experienced by ...

Activist investor Starboard Value has amassed a stake in chip maker Qorvo that’s worth half a billion dollars, according to a ...